Aprea Therapeutics APRE Insider Ownership

NASDAQ APRE
$0.79 -0.04 (-5.22%)
At close: Sep 9, 2026 · 4:00 PM EDT

Insider Holdings by Owner

1.10Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
0.066%
0% pp QoQ
Shares Held by Insiders
4.18K
filed for Sep 2026
0.00% QoQ
Shares Outstanding
6.37Mn
6,372,938 shares
Direct Holdings
4.18K
Indirect: 0
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
15
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest
Average ownership
Peak ownership

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter
Net over range
Buying quarters

Insider Ownership Summary

Quarter ending 30 Sep, 2026

APRE's three largest insider shareholders as of September 09, 2026 are Oren Gilad (President/Ceo, 393.89K shares), Oren Gilad (President/Ceo, 393.89K shares), Marc Duey (Director, 259.29K shares).

Form 4 Holdings

Insiders Holding APRE

Insiders 15
Shares held 1.10Mn
Of outstanding 17.24%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Oren Gilad President/Ceo 393,895 0 393,895 35.8% 16 Mar, 2026
2 Marc Duey Director 259,290 0 259,290 23.6% 17 Jun, 2026
3 Christian S Schade Chairman Ceo 259,246 0 259,246 23.6% 01 Aug, 2022
4 Bernd R. Seizinger Director 48,910 0 48,910 4.5% 17 Jun, 2026
5 Gregory Alan Korbel Svp, Chief Operating Officer 45,762 0 45,762 4.2% 01 Aug, 2022
6 John P. Hamill Srvp/Cfo/Prin Fin Acct Ofcr 43,528 0 43,528 4.0% 16 Mar, 2026
7 Rifat Pamukcu Director 8,581 0 8,581 0.8% 17 Jun, 2026
8 Scott M Coiante Svp, Chief Financial Officer 7,253 0 7,253 0.7% 01 Aug, 2022
9 Nadeem Q. Mirza Chief Medical Officer 6,730 0 6,730 0.6% 02 May, 2024
10 Richard Peters Director 6,254 0 6,254 0.6% 17 Jun, 2026
11 Michael Grissinger Director 6,024 0 6,024 0.5% 17 Jun, 2026
12 Gabriela Gruia Director 4,180 0 4,180 0.4% 17 Jun, 2026
13 Jean-Pierre Bizzari Director 4,180 0 4,180 0.4% 17 Jun, 2026
14 Eyal C. Attar Svp, Chief Medical Officer 2,862 0 2,862 0.3% 07 Jun, 2022
15 Lars B. Abrahmsen Svp, Chief Scientific Officer 2,185 0 2,185 0.2% 14 Mar, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

835 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
16 Jun, 2026 Jean-Pierre Bizzari Director Acquired A 3,135 $0.00 $0 4,180 Direct
16 Jun, 2026 Gabriela Gruia Director Acquired A 3,135 $0.00 $0 4,180 Direct
16 Jun, 2026 John B Iii Henneman Director Acquired A 3,135 $0.00 $0 13,364 Direct
16 Jun, 2026 Bernd R. Seizinger Director Acquired A 3,135 $0.00 $0 48,910 Direct
16 Jun, 2026 Michael Grissinger Director Acquired A 3,135 $0.00 $0 6,024 Direct
16 Jun, 2026 Marc Duey Director Acquired A 3,135 $0.00 $0 259,290 Direct
16 Jun, 2026 Rifat Pamukcu Director Acquired A 3,135 $0.00 $0 8,581 Direct
16 Jun, 2026 Richard Peters Director Acquired A 3,135 $0.00 $0 6,254 Direct
16 Jun, 2026 Gabriela Gruia Director Acquired A 12,555 $0.00 $0 12,555 Direct
16 Jun, 2026 Jean-Pierre Bizzari Director Acquired A 12,555 $0.00 $0 12,555 Direct
16 Jun, 2026 John B Iii Henneman Director Acquired A 12,555 $0.00 $0 12,555 Direct
16 Jun, 2026 Bernd R. Seizinger Director Acquired A 12,555 $0.00 $0 12,555 Direct
16 Jun, 2026 Richard Peters Director Acquired A 12,555 $0.00 $0 12,555 Direct
16 Jun, 2026 Michael Grissinger Director Acquired A 12,555 $0.00 $0 12,555 Direct
16 Jun, 2026 Marc Duey Director Acquired A 12,555 $0.00 $0 12,555 Direct
16 Jun, 2026 Rifat Pamukcu Director Acquired A 12,555 $0.00 $0 12,555 Direct
31 Mar, 2026 John P. Hamill Srvp/Cfo/Prin Fin Acct Ofcr Acquired P 30,978 $0.81 $25.00K 30,978 Direct
31 Mar, 2026 John P. Hamill Srvp/Cfo/Prin Fin Acct Ofcr Acquired P 30,978 $0.81 $25.00K 30,978 Direct
31 Mar, 2026 Richard Peters Director Acquired P 123,915 $0.81 $100.00K 123,915 Direct
31 Mar, 2026 Richard Peters Director Acquired P 123,915 $0.81 $100.00K 123,915 Direct